BioInvent International AB (publ)
BioInvent International AB (publ) (BOVNF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BOVNF · as of Jun 9, 2026
Key Statistics
Explore BioInvent International AB (publ) Data
bovnf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
bovnf competitorsBOVNF
AVCTF
CLVLY
CYDY
GSGTF
HLOSFStock Performance
Full HistoryAbout BioInvent International AB (publ)
BioInvent International AB (publ) is a clinical-stage biotechnology company primarily focused on identifying, exploring, and engineering immunomodulatory antibodies to combat various forms of cancer. …
what is bioinvent international ab (publ) · bovnf stock overview · bioinvent international ab (publ) company profile · who is bioinvent international ab (publ) ceo · bovnf OTC · bioinvent international ab (publ) headquarters · bioinvent international ab (publ) business segments
About Stock Overview & Key Data
BioInvent International AB (publ) (BOVNF) is a Healthcare company in the Biotechnology industry, listed on OTC since Sep 3, 2013. As of the latest trading session, BOVNF stock price is $6.63, with a market capitalization of $436.3M. The stock has returned +41.06% over the past 12 months and +101.52% year-to-date.
In fiscal year 2025, BioInvent International AB (publ) reported revenue of $225.9M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, BioInvent International AB (publ) (BOVNF) stock price is $6.63. The stock is traded on OTC under the ticker symbol BOVNF. The 52-week range is $3.29 – $6.63.